Related Experiment Video
Updated: Apr 21, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Endothelial damage and vascular calcification in patients with chronic kidney disease
Sagrario Soriano1, Andrés Carmona1, Francisco Triviño2
1Instituto Maimónides de Investigación Biomédica de Córdoba, Reina Sofía University Hospital, University of Córdoba, Córdoba, Spain; Nephrology Unit, Reina Sofía University Hospital, Córdoba, Spain; RETICs Red Renal (Instituto de Salud Carlos III), Madrid, Spain; and.
Insights
Vascular calcification in chronic kidney disease is linked to more endothelial microparticles and fewer endothelial progenitor cells. These microparticles may drive calcification by increasing osteocalcin expression in progenitor cells.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Cell Biology
Background:
- Vascular calcification (VC) is a significant complication in chronic kidney disease (CKD), increasing cardiovascular risks.
- Endothelial microparticles (MPs) and endothelial progenitor cells (EPCs) are implicated in vascular health and disease.
Purpose of the Study:
- To investigate the role of endothelial MPs and EPCs in the development of VC in CKD patients.
- To explore the mechanisms by which MPs and EPCs influence VC, particularly osteocalcin (OCN) expression.
Main Methods:
- Quantified circulating endothelial MPs and EPCs in CKD patients with and without VC.
- Assessed OCN expression in EPCs from CKD patients.
- Conducted in vitro experiments using MPs from CKD patients to induce OCN expression in healthy EPCs, vascular smooth muscle cells, and fibroblasts.
Main Results:
- CKD patients with VC had significantly higher levels of circulating endothelial MPs and lower percentages of EPCs compared to those without VC.
- EPCs expressing OCN were more numerous in CKD patients with VC.
- MPs from CKD patients induced OCN expression in healthy EPCs, vascular smooth muscle cells, and fibroblasts, with a more pronounced effect from MPs of VC patients.
Conclusions:
- An imbalance between endothelial damage (increased MPs) and repair (decreased EPCs) contributes to VC in CKD.
- EPCs, via OCN expression, may directly participate in the pathogenesis of vascular calcification in CKD patients.
Abstract:
Vascular calcification (VC) is a frequent complication of chronic kidney disease (CKD) and is a predictor of cardiovascular morbidity and mortality. In the present study, we investigated the potential involvement of endothelial microparticles (MPs) and endothelial progenitor cells (EPCs) in the generation of VC in CKD patients. The number of circulating EMPs is greater in patients with VC than without VC (307 ± 167 vs. 99 ± 75 EMPs/μl, P < 0.001). The percentage of EPCs is significantly lower in patient with VC than in patients without VC (0.14 ± 0.11% vs. 0.25 ± 0.18%, P = 0.002). The number of EPCs expressing osteocalcin (OCN) was higher in VC patients (349 ± 63 cells/100,000) than in non-VC patients (139 ± 75 cells/100,000, P < 0.01). In vitro, MPs obtained from CKD patients were able to induce OCN expression in EPCs from healthy donors; the increase in OCN expression was more accentuated if MPs were obtained from CKD patients with VC. MPs from CKD patients also induced OCN expression in vascular smooth muscle cells and fibroblasts. In CKD patients, the rise in endothelial MPs associated with a decrease in the number of EPCs, suggesting an imbalance in the processes of endothelial damage and repair in CKD patients, mainly those with VC. Our results suggest that EPCs, through OCN expression, may directly participate in the process of VC.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology

